Pricing Log in Create free account

Werewolf Therapeutics, Inc. (HOWL) vs Hyperion DeFi, Inc. (HYPD)

Werewolf Therapeutics, Inc. and Hyperion DeFi, Inc. are both Biotechnology companies. Werewolf Therapeutics, Inc. and Hyperion DeFi, Inc. are of similar size ($49.0M and $48.5M). Hyperion DeFi, Inc. grew revenue faster over the last twelve months: 1,990.6% against −5.21%. Werewolf Therapeutics, Inc. has the higher net margin (−141.9% vs −1,224.5%) and the lower return on invested capital (0.00% vs 2.73%). Across the 17 metrics below, Werewolf Therapeutics, Inc. leads on 9 and Hyperion DeFi, Inc. on 8.

Valuation

Metric HOWL HYPD Biotechnology median
P/E n/m n/m 8.50
P/S 1.95 28.74 9.71
P/B 2.92 0.39 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 7.98 0.64
EV/Sales 1.94 27.88 9.21
Earnings yield (74.49%) (217.96%) (33.15%)
Free cash flow yield (62.73%) (191.71%) (25.50%)

Profitability

Metric HOWL HYPD Biotechnology median
Gross margin 100.00% 78.35% 65.16%
Operating margin (128.18%) 314.32% 0.00%
Net margin (141.94%) (1,224.53%) 0.00%
Free cash flow margin (122.51%) (5,509.35%) 0.00%
Return on equity (119.86%) (24.63%) (56.36%)
Return on assets (59.31%) (20.32%) (48.04%)
Return on invested capital 0.00% 2.73% 0.00%

Growth

Metric HOWL HYPD Biotechnology median
Revenue growth (TTM) (5.21%) 1,990.60% 6.02%
EPS growth (last fiscal year) 18.40% 84.28% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric HOWL HYPD Biotechnology median
Debt to equity 0.00 0.08 0.00
Current ratio 2.91 2.34 4.72
Net debt to EBITDA 0.97 (0.03) 0.96

Dividend

Metric HOWL HYPD Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric HOWL HYPD Biotechnology median
Market cap 48.46m 48.95m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack